Organization: Health Canada
Year: 2022
Month: October
Request Number: A-2022-000550
Request Summary: Adverse Drug Reactions (ADRs) for IMMUNOGLOBULIN (HUMAN). Report numbers: E2B_05401556, 000990511. ADR for IDURSULFASE. Report number: E2B_05359472. ADR for ICATIBANT (ICATIBANT ACETATE). Report number: E2B_05321269. ADR for AGALSIDASE ALFA. Report number: E2B_05370282. ADR for TAKHZYRO. Report number: E2B_05338593. ADRs for LANSOPRAZOLE. Report numbers: E2B_05327428, E2B_05387909.
Disposition: Disclosed in part
Number of pages: 238